NCT05235958

Brief Summary

Exercise is a cornerstone of health care helping to improve and maintain a good organ functionality, including vascular function, in health and disease. About twenty years ago, the introduction of high-intensity training has been a milestone in the evolution of exercise therapy by demonstrating the trainability of individuals independent of age and state of disease. Today, its practical implementation still faces barriers, such as lower physical and mental tolerance of exercise, long-term adherence and lack of individualization of training for optimal adaptations. The proposed project is the logical next step to introduce non-linear periodized exercise training (NLPE), a method widely established in elite athletes, in exercise training of sedentary individuals. NLPE alternatingly involves person-centred periodization of training cycles and regeneration with high-intensity stimuli. It induces a broader range of physiological adaptations than moderate-intensity training while keeping a high compliance and without increasing the risk of overreaching. A study of patients with chronic-obstructive-pulmonary-disease and a study with resistance training of older adults indicated promising pulmonary and muscular effects. However, the effectiveness of NLPE to maintain and improve vascular function has not yet been assessed, although this may carry a huge clinical and socioeconomic potential by contributing to the reduction of cardiovascular morbidity and mortality. VascuFit applies an 8-week training intervention to assess the effects of NLPE on the function of the vascular endothelium, measured by the non-invasive gold-standard method brachial arterial flow-mediated dilation (baFMD), in a sample of sedentary aging adults with cardiovascular risk factors. In addition, it will be the first study to measure training effects on a cluster of micro-ribonucleic acids (miRNAs) regulating key molecular pathways of endothelial (dys-)function. Thus, VascuFit aims to explore the potential of clinical and molecular biomarkers for the monitoring of individual vascular adaptability to a specific type of exercise. As a first step, this pilot-project is supposed to deliver proof-of-concept. Furthermore, it will generate important hypotheses to be addressed by exercise physiologists, medical professionals and biologists concerned with the optimization of individual training adaptations as well as utility and implementation of targeted training approaches in the health care of aging adults. VascuFit aims to demonstrate the potential of NLPE as a training regimen to improve vascular function in sedentary individuals with elevated cardiovascular risk. This project may be the initial spark to raise exercise training to the next level, which is clearly necessary to sustainably strengthen the vascular capacities of "young" aging individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 11, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

May 2, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2023

Completed
Last Updated

December 4, 2023

Status Verified

November 1, 2023

Enrollment Period

8 months

First QC Date

February 1, 2022

Last Update Submit

November 28, 2023

Conditions

Keywords

endotheliumflow-mediated vasodilationsedentarycardiovascular riskaerobic exercisevascular ageing

Outcome Measures

Primary Outcomes (1)

  • Brachial-arterial flow-mediated vasodilation (baFMD)

    Non-invasive ultrasound-based measurement of endothelial responsiveness of the brachial artery to an hyperemic stimulus. Changes of baFMD after the 8-week study period in comparison to the pre-intervention baseline values will be assessed.

    8 weeks

Secondary Outcomes (1)

  • endomiR

    8 weeks

Other Outcomes (1)

  • Static retinal vessel analysis (SVA)

    8 weeks

Study Arms (2)

Training intervention

EXPERIMENTAL

8 weeks of non-linear periodized aerobic exercise; 3 sessions per week; 1 hour per session; standardized warm-up; individual training intensity according to cardiorespiratory fitness level

Other: non-linear periodized exercise (NLPE)

Control Intervention

SHAM COMPARATOR

Recommendation to continue with current lifestyle (especially physical activity habits) during the following 8 weeks. At the final assessment after 8 weeks, individualized exercise recommendations according to established standard procedures in exercise medicine and offer to attend the standard medical follow-up in our outpatient clinics subsequent to study termination

Other: Exercise counselling

Interventions

Aerobic training derived from professional sports, that is characterized by variable periodization of training frequency, volume and intensity according to individual factors, such as physical and mental readiness, training progress and performance level

Training intervention

Standard recommendations for exercise and physical activity, that are individualized according to a medical health and fitness profile

Control Intervention

Eligibility Criteria

Age40 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Informed consent, documented by signature
  • sedentary lifestyle, as not performing exercise on a regular basis and reaching less than the recommended 7.5 MET hours of at least moderate intensity activity per week
  • being mentally and physically able to attend and keep up training during the whole intervention period.

You may not qualify if:

  • current or chronic condition limiting exhaustive exercise (e.g. heart failure, infection, pulmonary disease)
  • any condition with elevated risk of a serious adverse event during exhaustive exercise (e.g. cardiomyopathy, acute myocardial infarction, stroke, uncontrolled hypertensive resting blood pressure ≥160/100mmHg)
  • chronic condition with severe affection of the vascular system (e.g. severe atherosclerosis, severe chronic kidney disease, autoimmune vasculitis, insulin dependent diabetes mellitus)
  • inability to follow advice during measurements and training sessions (e.g. language barriers, psychological disorders, dementia)
  • previous enrollment into the current study or participation in another study in the last four weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement of Sport, Exercise and Health

Basel, 4052, Switzerland

Location

Related Publications (1)

  • Konigstein K, Meier J, Angst T, Maurer DJ, Kropfl JM, Carrard J, Infanger D, Baumann S, Bischofsberger I, Harder M, Jaggi Y, Wettach S, Hanssen H, Schmidt-Trucksass A. VascuFit: vascular effects of non-linear periodized exercise training in sedentary adults with elevated cardiovascular risk - protocol for a randomized controlled trial. BMC Cardiovasc Disord. 2022 Oct 27;22(1):449. doi: 10.1186/s12872-022-02905-1.

MeSH Terms

Conditions

Sedentary Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Karsten Königstein, Dr. med.

    University of Basel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized controlled training intervention (8-weeks) with assessment of changes in clinical and molecular vascular biomarkers compared to their baseline value before the intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Scientist

Study Record Dates

First Submitted

February 1, 2022

First Posted

February 11, 2022

Study Start

May 2, 2022

Primary Completion

December 21, 2022

Study Completion

February 28, 2023

Last Updated

December 4, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

After publication of the results, anonymized data and analytic codes may be shared upon request by the principal investigator (Dr. K. Königstein)

Shared Documents
ANALYTIC CODE
Time Frame
After publication of the study results.
Access Criteria
Justified request to the principle investigator (Dr. K. Königstein), i.e. reproduction of the study results, meta-analysis about a related scientific problem/question., data sampling for a big data project.

Locations